As of 11:32am ET
| -0.275 / -7.72%|
The 4 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +219.63% increase from the last price of 3.29.
The current consensus among 4 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.